Cargando…
Gene therapies for high-grade gliomas: from the bench to the bedside
BACKGROUND: Gene therapy is the most attractive therapeutic approach against high-grade gliomas (HGGs). This is because of its theoretical capability to rework gene makeup in order to yield oncolytic effects. However, some factors still limit the upgrade of these therapies at a clinical level of evi...
Autores principales: | Giotta Lucifero, Alice, Luzzi, Sabino, Brambilla, Ilaria, Guarracino, Carmen, Mosconi, Mario, Foiadelli, Thomas, Savasta, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975827/ https://www.ncbi.nlm.nih.gov/pubmed/32608374 http://dx.doi.org/10.23750/abm.v91i7-S.9953 |
Ejemplares similares
-
Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
Innovative therapies for malignant brain tumors: the road to a tailored cure
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
The impact of stem cells in neuro-oncology: applications, evidence, limitations and challenges
por: Luzzi, Sabino, et al.
Publicado: (2020) -
Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges
por: Luzzi, Sabino, et al.
Publicado: (2020) -
Targeting the medulloblastoma: a molecular-based approach
por: Luzzi, Sabino, et al.
Publicado: (2020)